Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-09-19 Hunt Anthony Chief Executive Officer Sale −452 $83.72 $38K 219,413
2019-09-19 Hunt Anthony Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −20,000 18,127
2019-09-09 Hunt Anthony Chief Executive Officer Sale −4,131 $81.26 $336K 210,976
2019-09-09 Hunt Anthony Chief Executive Officer Sale −4,926 $82.15 $405K 206,050
2019-09-09 Hunt Anthony Chief Executive Officer Sale −1,751 $83.05 $145K 204,299
2019-09-09 Hunt Anthony Chief Executive Officer Sale −740 $84.64 $63K 203,559
2019-09-09 Hunt Anthony Chief Executive Officer Sale −222 $86.26 $19K 203,337
2019-09-09 Hunt Anthony Chief Executive Officer Sale −288 $89.27 $26K 203,049
2019-09-09 Hunt Anthony Chief Executive Officer Sale −36 $90.31 $3K 203,013
2019-07-15 Snodgres Jon Chief Financial Officer Shares withheld for taxes −295 $85.95 $25K 28,239
2019-06-17 DAWES KAREN A Director Exercise or conversion +20,000 $4.96 $99K 118,329
2019-06-17 DAWES KAREN A Director Sale −1,295 $77.35 $100K 117,034
2019-06-17 DAWES KAREN A Director Exercise or conversion · Stock Options (Right to Buy) −20,000 0
2019-05-23 COOPER GLENN L MD Director Exercise or conversion +24,000 $5.00 $120K 64,709
2019-05-23 COOPER GLENN L MD Director Sale −4,734 $66.91 $317K 59,975
2019-05-23 COOPER GLENN L MD Director Sale −266 $67.53 $18K 59,709
2019-05-23 COOPER GLENN L MD Director Exercise or conversion · Stock Option (Right to Buy) −24,000 0
2019-05-23 COOPER GLENN L MD Director Sale −4,734 $66.91 $317K 35,975
2019-05-23 COOPER GLENN L MD Director Sale −266 $67.53 $18K 35,709
2019-05-15 RYAN THOMAS F JR Director Grant or award +923 4,148

Page 41 of 42 · 832 trades